|
1
|
Preventing complications of central venous catheterization.
|
N Engl J Med
|
2003
|
16.18
|
|
2
|
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
10.75
|
|
3
|
Benefits and harms of CT screening for lung cancer: a systematic review.
|
JAMA
|
2012
|
8.71
|
|
4
|
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations.
|
Am J Respir Crit Care Med
|
2006
|
5.29
|
|
5
|
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
|
Chest
|
2013
|
3.82
|
|
6
|
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).
|
Chest
|
2007
|
3.36
|
|
7
|
Lung cancer incidence in never smokers.
|
J Clin Oncol
|
2007
|
3.20
|
|
8
|
Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol.
|
Chest
|
2004
|
2.89
|
|
9
|
Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques.
|
J Vasc Interv Radiol
|
2009
|
2.79
|
|
10
|
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
|
Chest
|
2007
|
2.72
|
|
11
|
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.
|
Perm J
|
2012
|
2.55
|
|
12
|
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules.
|
Chest
|
2014
|
2.30
|
|
13
|
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2009
|
2.19
|
|
14
|
Lung cancer screening.
|
Am J Respir Crit Care Med
|
2015
|
2.14
|
|
15
|
Decision making in patients with pulmonary nodules.
|
Am J Respir Crit Care Med
|
2011
|
2.05
|
|
16
|
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.
|
Ann Intern Med
|
2009
|
1.99
|
|
17
|
Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
|
Arch Neurol
|
2006
|
1.92
|
|
18
|
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules.
|
Chest
|
2013
|
1.79
|
|
19
|
Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease.
|
Ann Am Thorac Soc
|
2014
|
1.74
|
|
20
|
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.
|
Health Qual Life Outcomes
|
2005
|
1.69
|
|
21
|
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.
|
Am J Respir Crit Care Med
|
2011
|
1.58
|
|
22
|
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review.
|
J Thorac Oncol
|
2009
|
1.57
|
|
23
|
Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia.
|
Chest
|
2003
|
1.56
|
|
24
|
Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing.
|
J Thorac Oncol
|
2012
|
1.54
|
|
25
|
When the average applies to no one: personalized decision making about potential benefits of lung cancer screening.
|
Ann Intern Med
|
2012
|
1.51
|
|
26
|
Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans.
|
Chest
|
2009
|
1.51
|
|
27
|
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease.
|
J Allergy Clin Immunol
|
2007
|
1.50
|
|
28
|
Timeliness across the continuum of care in veterans with lung cancer.
|
J Thorac Oncol
|
2008
|
1.49
|
|
29
|
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes.
|
Am J Respir Crit Care Med
|
2010
|
1.45
|
|
30
|
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition).
|
Chest
|
2007
|
1.39
|
|
31
|
Health-related quality of life among patients with idiopathic pulmonary fibrosis.
|
Chest
|
2005
|
1.36
|
|
32
|
The pathogenetic and prognostic value of biologic markers in acute lung injury.
|
J Intensive Care Med
|
2009
|
1.36
|
|
33
|
Health-related quality of life in patients with pulmonary arterial hypertension.
|
Chest
|
2004
|
1.34
|
|
34
|
Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
|
Chest
|
2012
|
1.34
|
|
35
|
Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure.
|
Chest
|
2009
|
1.28
|
|
36
|
Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis.
|
Ann Intern Med
|
2006
|
1.17
|
|
37
|
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
|
Chest
|
2015
|
1.16
|
|
38
|
Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.
|
Liver Transpl
|
2009
|
1.15
|
|
39
|
Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator.
|
Chest
|
2005
|
1.14
|
|
40
|
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.
|
Chest
|
2015
|
1.11
|
|
41
|
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
|
Chest
|
2009
|
1.07
|
|
42
|
Randomized trials and bronchoscopy.
|
Chest
|
2013
|
1.05
|
|
43
|
Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
|
Chest
|
2013
|
1.03
|
|
44
|
Clinical practice. Lung-cancer screening with low-dose computed tomography.
|
N Engl J Med
|
2014
|
1.00
|
|
45
|
Risks of Transthoracic Needle Biopsy: How High?
|
Clin Pulm Med
|
2013
|
0.98
|
|
46
|
Hospital characteristics associated with timeliness of care in veterans with lung cancer.
|
Am J Respir Crit Care Med
|
2008
|
0.96
|
|
47
|
Computed tomography screening for lung cancer.
|
Ann Intern Med
|
2013
|
0.96
|
|
48
|
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice.
|
Am J Respir Crit Care Med
|
2015
|
0.96
|
|
49
|
Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables.
|
Med Care
|
2010
|
0.96
|
|
50
|
Patient preference and contraindications in measuring quality of care: what do administrative data miss?
|
J Clin Oncol
|
2013
|
0.95
|
|
51
|
'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule.
|
Health Expect
|
2012
|
0.94
|
|
52
|
Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery.
|
Thorax
|
2011
|
0.91
|
|
53
|
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.
|
Am J Respir Crit Care Med
|
2015
|
0.90
|
|
54
|
An official American thoracic society workshop report: developing performance measures from clinical practice guidelines.
|
Ann Am Thorac Soc
|
2014
|
0.90
|
|
55
|
Variation in experts' beliefs about lung cancer growth, progression, and prognosis.
|
J Thorac Oncol
|
2008
|
0.85
|
|
56
|
Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates.
|
Med Decis Making
|
2003
|
0.85
|
|
57
|
Multidisciplinary management of lung cancer.
|
N Engl J Med
|
2004
|
0.85
|
|
58
|
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer.
|
J Thorac Oncol
|
2006
|
0.85
|
|
59
|
Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report.
|
Chest
|
2015
|
0.83
|
|
60
|
Determinants of health utility in lung and heart-lung transplant recipients.
|
Am J Transplant
|
2005
|
0.82
|
|
61
|
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.
|
Arch Intern Med
|
2007
|
0.82
|
|
62
|
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology.
|
Syst Rev
|
2014
|
0.81
|
|
63
|
Delays in lung cancer care: time to improve.
|
J Thorac Oncol
|
2009
|
0.80
|
|
64
|
Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients.
|
Am J Med
|
2005
|
0.80
|
|
65
|
The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers.
|
AJR Am J Roentgenol
|
2003
|
0.80
|
|
66
|
Minimally invasive techniques for the diagnosis of peripheral pulmonary nodules.
|
Curr Opin Pulm Med
|
2008
|
0.79
|
|
67
|
The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization.
|
Subst Use Misuse
|
2013
|
0.79
|
|
68
|
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort.
|
BMC Cancer
|
2011
|
0.79
|
|
69
|
Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF.
|
Am J Respir Crit Care Med
|
2005
|
0.78
|
|
70
|
Favorable stage distribution in the NELSON trial: promise or hype?
|
Am J Respir Crit Care Med
|
2013
|
0.78
|
|
71
|
Facility characteristics and quality of lung cancer care in an integrated health care system.
|
J Thorac Oncol
|
2014
|
0.78
|
|
72
|
Low-value care for acute sinusitis encounters: who's choosing wisely?
|
Am J Manag Care
|
2015
|
0.77
|
|
73
|
CT screening for lung cancer.
|
N Engl J Med
|
2007
|
0.77
|
|
74
|
Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report.
|
Chest
|
2015
|
0.76
|
|
75
|
The use and misuse of positron emission tomography in lung cancer evaluation.
|
Clin Chest Med
|
2011
|
0.76
|
|
76
|
Predicting in-hospital mortality among critically ill patients with end-stage liver disease.
|
J Crit Care
|
2012
|
0.76
|
|
77
|
Attitudes about low-dose computed tomography screening for lung cancer: a survey of American Thoracic Society Clinicians.
|
Am J Respir Crit Care Med
|
2015
|
0.75
|
|
78
|
Predicting outcomes in chronic obstructive pulmonary disease.
|
N Engl J Med
|
2004
|
0.75
|
|
79
|
Lung cancer screening debate.
|
Chest
|
2003
|
0.75
|
|
80
|
Reply: Lung Cancer Screening: The Balance between Harm and Benefit.
|
Am J Respir Crit Care Med
|
2015
|
0.75
|
|
81
|
Advancing clinical practice and policy through guidelines: the role of the American Thoracic Society.
|
Am J Respir Crit Care Med
|
2013
|
0.75
|
|
82
|
Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant.
|
Ann Am Thorac Soc
|
2013
|
0.75
|
|
83
|
Response.
|
Chest
|
2013
|
0.75
|
|
84
|
Lung cancer screening and elderly adults: do we have sufficient evidence?
|
Ann Intern Med
|
2014
|
0.75
|
|
85
|
Thromboprophylaxis in the real world: strengths and limitations of comparative effectiveness research.
|
Chest
|
2011
|
0.75
|
|
86
|
Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion?
|
Chest
|
2008
|
0.75
|
|
87
|
Does statin use attenuate lung function decline?
|
Am J Respir Crit Care Med
|
2008
|
0.75
|
|
88
|
Clinical guidelines for the treatment of ventilator-associated pneumonia.
|
Crit Care Med
|
2002
|
0.75
|
|
89
|
The five commandments of efficient and effective care in the initial evaluation of lung cancer.
|
Curr Opin Pulm Med
|
2016
|
0.75
|
|
90
|
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.
|
Am J Respir Crit Care Med
|
2017
|
0.75
|
|
91
|
Improving antibiotic stewardship: a stepped-wedge cluster randomized trial.
|
Am J Manag Care
|
2017
|
0.75
|
|
92
|
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.
|
Am J Respir Crit Care Med
|
2017
|
0.75
|
|
93
|
Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.
|
Curr Opin Pulm Med
|
2008
|
0.75
|
|
94
|
An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.
|
Am J Respir Crit Care Med
|
2016
|
0.75
|
|
95
|
Impact of pulmonary rehabilitation on hospitalizations for chronic obstructive pulmonary disease among members of an integrated health care system.
|
J Cardiopulm Rehabil Prev
|
2015
|
0.75
|
|
96
|
Low-value antibiotic prescribing and clinical factors influencing patient satisfaction.
|
Am J Manag Care
|
2017
|
0.75
|
|
97
|
Choosing Wisely(®) in pulmonary medicine.
|
Am J Respir Crit Care Med
|
2014
|
0.75
|
|
98
|
Preventing venous thromboembolism in the intensive care unit: A no-brainer?
|
J Crit Care
|
2005
|
0.75
|